Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Antidiarrheal prophylaxis with loperamide for patients with lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive breast cancer who received adjuvant pyrotinib plus nab-paclitaxel: a randomized sub-study of PHAEDRA
Wang, Changjun; Lin, Yan; Zhou, Yidong; Mao, Feng; Guan, Jinghong; Shen, Songjie; Wang, Xuejing; Zhang, Xiaohui; Zhang, Yanna; Pan, Bo; Zhong, Ying; Peng, Li; Li, Yan; Huang, Xin; Xu, Ying; Sun, Qiang Share Save LncRNA-AP006284.1 promotes prostate cancer cell growth and motility by forming RNA-DNA triplexes and recruiting GNL3/SFPQ complex to facilitate RASSF7 transcriptionLu, Yali; Lin, Yan; Zhang, Xiaoyang; Yan, Jun; Kong, Zhe; Zhang, Lu; Wang, Chenji; Huang, Yan; Zhao, Shimin; Li, Yao Share Save Share Save Share Save Share Save Phase II study of pyrotinib plus nanoparticle albumin-bound (nab)-paclitaxel as adjuvant therapy for lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive early breast cancer (PHAEDRA)Wang, Changjun; Zhou, Yidong; Lin, Yan; Mao, Feng; Guan, Jinghong; Zhang, Xiaohui; Shen, Songjie; Wang, Xuejing; Zhang, Yanna; Pan, Bo; Zhong, Ying; Peng, Li; Cao, Xi; Yao, Ru; Zhou, Xingtong; Xu, Chi; Xu, Ying; Sun, Qiang Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
